Suppachok Kirdlarp

803 total citations
19 papers, 156 citations indexed

About

Suppachok Kirdlarp is a scholar working on Infectious Diseases, Neurology and Epidemiology. According to data from OpenAlex, Suppachok Kirdlarp has authored 19 papers receiving a total of 156 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 7 papers in Neurology and 5 papers in Epidemiology. Recurrent topics in Suppachok Kirdlarp's work include COVID-19 Clinical Research Studies (9 papers), Long-Term Effects of COVID-19 (7 papers) and SARS-CoV-2 and COVID-19 Research (6 papers). Suppachok Kirdlarp is often cited by papers focused on COVID-19 Clinical Research Studies (9 papers), Long-Term Effects of COVID-19 (7 papers) and SARS-CoV-2 and COVID-19 Research (6 papers). Suppachok Kirdlarp collaborates with scholars based in Thailand and United States. Suppachok Kirdlarp's co-authors include Sirawat Srichatrapimuk, Somnuek Sungkanuparph, Darunee Chotiprasitsakul, Pitak Santanirand, Kulapong Jayanama, Suwimon Manopwisedjaroen, Arunee Thitithanyanont, Suradej Hongeng, Supawadee Suppadungsuk and Chavachol Setthaudom and has published in prestigious journals such as PLoS ONE, American Journal of Tropical Medicine and Hygiene and International Journal of Infectious Diseases.

In The Last Decade

Suppachok Kirdlarp

16 papers receiving 154 citations

Peers

Countries citing papers authored by Suppachok Kirdlarp

Since Specialization

Citations

This map shows the geographic impact of Suppachok Kirdlarp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suppachok Kirdlarp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suppachok Kirdlarp more than expected).

Fields of papers citing papers by Suppachok Kirdlarp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suppachok Kirdlarp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suppachok Kirdlarp. The network helps show where Suppachok Kirdlarp may publish in the future.

Co-authorship network of co-authors of Suppachok Kirdlarp

This figure shows the co-authorship network connecting the top 25 collaborators of Suppachok Kirdlarp. A scholar is included among the top collaborators of Suppachok Kirdlarp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suppachok Kirdlarp. Suppachok Kirdlarp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Isolated Adrenal Abscess Due to Melioidosis 2025 ·American Journal of Tropical Medicine and Hygiene ·(unknown), (unknown), (unknown), Suppachok Kirdlarp, Chutintorn Sriphrapradang	0
2	Remdesivir versus Favipiravir in Hospitalized Patients with Moderate to Severe COVID-19 Pneumonia: A Propensity Score-Matched Retrospective Cohort Study 2024 ·International Journal of General Medicine ·(unknown), Yuda Sutherasan, Tananchai Petnak, (unknown), Suppachok Kirdlarp, Viboon Boonsarngsuk, Somnuek Sungkanuparph	0
3	Prevalence and risk factors of cytomegalovirus reactivation in critically Ill patients with COVID-19 pneumonia 2024 ·PLoS ONE ·(unknown), Somnuek Sungkanuparph, Sirawat Srichatrapimuk, (unknown), (unknown), Kulapong Jayanama, Suppachok Kirdlarp	8
4	Immunogenicity of a fractional or full third dose of AZD1222 vaccine or BNT162b2 messenger RNA vaccine after two doses of CoronaVac vaccines against the Delta and Omicron variants 2023 ·International Journal of Infectious Diseases ·(unknown), Anan Jongkaewwattana, (unknown), Nawamin Pinpathomrat, Sira Nanthapisal, Nattiya Hirankarn, Sarawut Siwamogsatham, Suppachok Kirdlarp, Romanee Chaiwarith, Saranath Lawpoolsri, (unknown), Arunee Thitithanyanont, Pokrath Hansasuta, Sansanee C. Chaiyaroj, Punnee Pitisuttithum	6
5	Potential drug–drug interactions of frequently prescribed medications in long COVID detected by two electronic databases 2023 ·PLoS ONE ·(unknown), Supawit Tangpanithandee, (unknown), (unknown), Pisut Pongchaikul, Suppachok Kirdlarp, Phisit Khemawoot, Surakit Nathisuwan	1
6	Increased platelet activation and lower platelet-monocyte aggregates in COVID-19 patients with severe pneumonia 2023 ·PLoS ONE ·(unknown), (unknown), Sirawat Srichatrapimuk, Pornpun Vivithanaporn, Suppachok Kirdlarp, Somnuek Sungkanuparph, (unknown), (unknown), Prasit Suwannalert, Nathawut Sibmooh	5
7	Remdesivir versus favipiravir in hospitalized patients with moderate COVID-19 pneumonia: A propensity score-matched retrospective cohort study. 2023 ·(unknown), (unknown), Viboon Boonsarngsuk, (unknown), (unknown), Suppachok Kirdlarp, Yuda Sutherasan	2
8	Intraluminal catheter colonisation: A clue for establishing the microbiologic diagnosis of peritoneal dialysis-related fungal peritonitis 2023 ·Peritoneal Dialysis International ·(unknown), (unknown), (unknown), (unknown), Suppachok Kirdlarp, Talerngsak Kanjanabuch	0
9	SARS-CoV-2 RT-PCR positivity of individuals subsequent to completing quarantine upon entry into a country during a transmission-free period 2022 ·Travel Medicine and Infectious Disease ·Sirawat Srichatrapimuk, Thanat Chookajorn, Theerarat Kochakarn, Suppachok Kirdlarp, Ekawat Pasomsub, Wasun Chantratita, Sopon Iamsirithaworn, Mongkol Kunakorn, Arunee Thitithanyanont, Somnuek Sungkanuparph, Angsana Phuphuakrat	3
10	Spontaneous tension hemothorax in a severe COVID-19 patient receiving ECMO therapy: The other side of COVID-19-associated coagulopathy 2022 ·Respiratory Medicine Case Reports ·(unknown), (unknown), Pongdhep Theerawit, Yuda Sutherasan, (unknown), Supawadee Suppadungsuk, (unknown), Suppachok Kirdlarp, Somnuek Sungkanuparph, Sirawat Srichatrapimuk	1
11	Detectable Duration of Viable SARS-CoV-2, Total and Subgenomic SARS-CoV-2 RNA in Noncritically Ill COVID-19 Patients: a Prospective Cohort Study 2022 ·Microbiology Spectrum ·Angsana Phuphuakrat, Ekawat Pasomsub, Sirawat Srichatrapimuk, Suppachok Kirdlarp, Ampa Suksatu, (unknown), Suwimon Manopwisedjaroen, (unknown), (unknown), (unknown), (unknown), Ammarin Thakkinstian, Suradej Hongeng, Kumthorn Malathum, Arunee Thitithanyanont, Boonrat Tassaneetrithep	11
12	The association between body mass index and severity of Coronavirus Disease 2019 (COVID-19): A cohort study 2021 ·PLoS ONE ·Kulapong Jayanama, Sirawat Srichatrapimuk, (unknown), Suppachok Kirdlarp, Supawadee Suppadungsuk, (unknown), (unknown), (unknown), (unknown), Somnuek Sungkanuparph	21
13	SARS‐CoV‐2 neutralizing antibodies decline over one year and patients with severe COVID‐19 pneumonia display a unique cytokine profile 2021 ·International Journal of Infectious Diseases ·(unknown), Sirawat Srichatrapimuk, Suwimon Manopwisedjaroen, Suppachok Kirdlarp, (unknown), Chavachol Setthaudom, (unknown), Prapaporn Pisitkun, Mongkol Kunakorn, Suradej Hongeng, Somnuek Sungkanuparph, Arunee Thitithanyanont	12
14	A Prospective Study of Cytomegalovirus-Specific Cell-Mediated Immune Monitoring and Cytomegalovirus Infection in Patients With Active Systemic Lupus Erythematosus Receiving Immunosuppressants 2021 ·Open Forum Infectious Diseases ·Jackrapong Bruminhent, (unknown), Porpon Rotjanapan, (unknown), (unknown), Suppachok Kirdlarp, (unknown), Chavachol Setthaudom, Prapaporn Pisitkun	6
15	Mice Immunized with the Vaccine Candidate HexaPro Spike Produce Neutralizing Antibodies against SARS-CoV-2 2021 ·Vaccines ·(unknown), (unknown), Kanit Bhukhai, (unknown), Suwimon Manopwisedjaroen, (unknown), (unknown), (unknown), Niwat Kangwanrangsan, Sirawat Srichatrapimuk, Suppachok Kirdlarp, Somnuek Sungkanuparph, Somchai Chutipongtanate, Arunee Thitithanyanont, Suradej Hongeng, Patompon Wongtrakoongate	15
16	Clinical features of adult patients with a definite diagnosis of central nervous system tuberculosis in an endemic country: A 13-year retrospective review 2020 ·Journal of Clinical Tuberculosis and Other Mycobacterial Diseases ·Suppachok Kirdlarp, Sirawat Srichatrapimuk, Sasisopin Kiertiburanakul, Angsana Phuphuakrat	2
17	Role of clinical pharmacists in telemonitoring for patients with Coronavirus Disease 2019 (COVID‐19) 2020 ·Journal of Clinical Pharmacy and Therapeutics ·(unknown), Somnuek Sungkanuparph, Suppachok Kirdlarp, (unknown), (unknown)	18
18	<p>Epidemiology of carbapenem-resistant Enterobacteriaceae: a 5-year experience at a tertiary care hospital</p> 2019 ·Infection and Drug Resistance ·Darunee Chotiprasitsakul, Sirawat Srichatrapimuk, Suppachok Kirdlarp, (unknown), Pitak Santanirand	43
19	1174. Epidemiology of Carbapenem-Resistant Enterobacteriaceae, a 5-Year Experience at a Tertiary Care Hospital 2018 ·Open Forum Infectious Diseases ·Darunee Chotiprasitsakul, Sirawat Srichatrapimuk, Suppachok Kirdlarp, Pitak Santanirand	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact